Welcure Drugs & Pharmaceuticals Ltd. - Research Center
524661 WELCURE Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
13.44 |
12.12 |
12.12 |
12.12 |
12.12 |
Share application money
Preference share capital
Reserves & surplus
-11.92 |
-12.03 |
-12.05 |
-12.10 |
-12.09 |
Secured loans
Unsecured loans
Total
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
Miscellaneous expenses not written
Total
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
135.12 |
135.12 |
135.12 |
135.12 |
135.12 |